查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
周邊液體栓塞劑市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍：按類型、應用和地理位置
市場調查報告書
商品編碼
1509785

周邊液體栓塞劑市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍：按類型、應用和地理位置

Peripheral Liquid Embolic Agents Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Application, and Geography
出版日期: | 出版商: The Insight Partners | 英文 233 Pages | 訂單完成後即時交付

價格

周邊液體栓塞劑市場預計將從2023年的4,042萬美元成長到2031年的8,141萬美元；預計2023年至2031年複合年成長率為9.1%。

周邊液體栓塞劑是介入放射學手術中用於阻塞滲漏血管和畸形的物質。這些藥物在注射後凝固，形成阻塞並阻止血液流向目標區域。

溫度誘導相變系統和 pH 值觸發栓塞劑的發展成為市場成長的趨勢

液體栓塞是生物工程領域非常感興趣的議題，特別是在周邊手術中。液體栓塞劑可以穿透線圈或導管無法到達的周邊、病灶或遠端區域。目前使用的液體栓塞劑雖然可以滿足大多數臨床需求，但也有一些缺點。因此，人們開發了各種新型液體栓塞劑來改善影像特性、減少併發症、最佳化流動性能並實現載藥能力。對其他重要材料特性的系統研究，例如相關副作用（例如毒性和黏附）、生物功能（生物相容性、生物可分解性、生物力學和生物活性）和射線不透性，對於在微量介入領域開發臨床客製化的栓塞劑至關重要。

溫度敏感的聚合物溶液在體內可以從溶膠注射狀態轉變為室溫下的凝膠狀態。聚(N-異丙基丙烯醯胺) (PNIPAAm) 在 32 °C 的較低臨界溶解溫度 (LCST) 下表現出可逆相變。根據Qian等人在《受控釋放雜誌》上發表的一項研究。 2015年，聚（N-異丙基丙烯醯胺-共-丁基甲基丙烯酸酯）凝膠與碘海醇分散體用於肝癌TACE，證明可有效栓塞家兔腎動脈並持續釋放阿黴素。同樣，根據 Wang 等人在國家醫學圖書館發表的一項研究。 2011年，殼聚醣/B-磷酸甘油（C/GP）成功閉合了兔子的腎動脈，顯示其是潛在的栓塞劑。同樣，趙等人。根據2011 年Wiley Online Library 發表的一項研究，還研究了用於栓塞的溫度敏感的PNIPAAm-iohexol 奈米凝膠。的分層3D 凝膠網路。與周邊栓塞劑碘化油相比，奈米凝膠在兔子 VX2 肝腫瘤中提供了更好的周邊栓塞效果。

此外，含有熱敏液體栓塞水凝膠的泊洛沙姆407（聚環氧乙烷a-聚環氧丙烷b-聚環氧乙烷a的三嵌段共聚物）已被提議用於肝癌治療。這種由泊洛沙姆407、羥甲基纖維素、海藻酸鈉和碘克沙醇(PSHI) 組成的複合水凝膠隨著溫度的升高呈現出兩相：流動的溶膠和收縮的凝膠。值得注意的是，隨著腫瘤在栓塞後消失，PSHI-Ca2+ 證明了 VX2 肝癌模型的完全閉塞。

pH敏感活性成分由於體外和生理環境之間的pH變化而經歷相變。這些水凝膠會根據 pH 值而膨脹和塌陷，控制藥物釋放。

根據 Nguyen 等人在英國皇家化學學會發表的一項研究。 2016年，開發出PCLA-PUSSM，這是一種由聚(ε-己內酯-共-丙交酯)(PCLA)、PEG和聚(氨基甲酸酯硫化物磺胺二甲嗪)(PUSSM)組成的共聚物，用於HCC的TACE。這種可生物分解的材料載有阿黴素，並隨著 pH 值的降低而表現出相變。此水凝膠成功栓塞了 VX2 兔子腫瘤模型的肝腫瘤，同時提供阿黴素的持續釋放。在大鼠模型中，栓塞阻止了腫瘤的血液供應，透過缺氧創造了酸性環境並誘導乳酸性酸中毒。低pH值觸發藥物釋放並成功抑制體內腫瘤生長。

以下列出了一些正在試驗的溫度敏感型和 pH 觸發型液體栓塞劑：

  • 表 1. 正在試驗溫度敏感和 pH 觸發凝膠化的液體栓塞劑

液態栓塞劑機理優勢經典使用情境或試用條件

殼聚醣/B-甘油磷酸（殼聚醣/B-GP） 溫度和 pH 觸發凝膠化 藥物傳輸 兔子腎動脈

絲彈性蛋白樣蛋白 (SELP) 溫度觸發凝膠化 藥物傳遞 兔子原發性 VX2 肝腫瘤

聚（N-異丙基丙烯醯胺-甲基丙烯酸丁酯）奈米凝膠（PIB 奈米凝膠） 溫度引發凝膠 比碘油更好的栓塞 兔子原發性 VX2 肝腫瘤

泊洛沙姆 407 溫度觸發凝膠化 暫時性血管阻塞 犬腎動脈

泊洛沙姆 407、海藻酸鈉、羥甲基纖維素、碘克沙醇和鈣離子 (PSHI-Ca2+) 溫度觸發凝膠化 不透射線 兔子原發性 VX2 肝腫瘤

基於磺胺二甲嘧啶的水凝膠 pH 觸發凝膠化 藥物傳遞 兔子原發性 VX2 肝腫瘤

聚（氨基酯聚氨酯）嵌段聚合物 (PEAU) 溫度和 pH 觸發凝膠化 藥物傳輸 兔子原發性 VX2 肝腫瘤

因此，對溫度誘導相變系統和 pH 觸發栓塞劑的日益關注和發展預計將在未來幾年為周邊液體栓塞劑市場帶來新趨勢。

周邊液體栓塞劑市場分析是透過考慮以下細分市場進行的：類型、應用和地理位置。根據類型，周邊液體栓塞劑市場分為聚合液體栓塞劑和沈澱液體栓塞劑。從應用來看，周邊液體栓塞劑市場分為內漏II型、畸形、出血與創傷、靜脈曲張、腫瘤、內臟動脈瘤等。

周邊液體栓塞劑市場報告的範圍涵蓋北美（美國、加拿大和墨西哥）、歐洲（西班牙、英國、德國、法國、義大利和歐洲其他地區）、亞太地區（韓國、中國） 、日本、印度、澳洲和亞太其他地區）、中東和非洲（南非、沙烏地阿拉伯、阿拉伯聯合大公國以及中東和非洲其他地區）以及南美洲和中美洲（巴西、阿根廷和南美洲和中美洲其他地區）。北美是全球周邊液體栓塞劑市場的最大貢獻者。預計 2023 年至 2031 年，亞太地區的複合年成長率將達到最高。

北美區域市場的成長歸因於該地區動脈瘤、創傷等病例的增加。由於政府對解決日益成長的周邊疾病擔憂的支持不斷增加，預計加拿大市場將會成長。由於製藥業和醫療旅遊業的發展，墨西哥的市場預計將成長。亞太地區周邊液體栓塞劑市場分為中國、日本、印度、澳洲、韓國和亞太其他地區。該地區的市場成長受到多種因素的推動，例如周邊動脈疾病（PAD）盛行率的上升、對微創手術的需求不斷增加、醫院和門診手術中心數量不斷增加、市場參與者對發展中國家的日益關注以及發展亞太地區的醫療保健基礎設施

疾病管制與預防中心 (CDC)、歐洲藥品管理局 (EMA)、泛美衛生組織 (PAHO) 和世界衛生組織 (WHO) 是在準備外圍報告時提到的幾個關鍵的主要和次要來源液體栓塞劑市場。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 重要見解

第 3 章：研究方法

  • 二次研究
  • 初步研究
    • 假設表述：
    • 宏觀經濟因素分析：
    • 顯影基數：
    • 數據三角測量：
    • 國家級資料：

第 4 章：周邊液體栓塞劑市場格局

  • 概述
  • PEST分析
  • 2023 年區域定價分析

第 5 章：周邊液體栓塞劑市場 - 主要市場動態

  • 周邊液體栓塞劑市場 - 主要市場動態
  • 市場促進因素
    • 周圍血管疾病的發生率上升
    • 微創手術的需求不斷增加
  • 市場限制
    • 栓塞劑成本高
  • 市場機會
    • 市場參與者不斷增加的策略性舉措
  • 未來的趨勢
    • 溫度誘導相變系統和 pH 觸發栓塞劑的進展
  • 影響分析

第 6 章：周邊液體栓塞劑市場 - 全球市場分析

  • 周邊液體栓塞劑市場收入，2021-2031
  • 周邊液體栓塞劑市場分析
  • 2023 年市場定位分析

第 7 章：周邊液體栓塞劑市場分析 - 按類型

  • 聚合液體栓塞劑
  • 沉澱液體栓塞劑

第 8 章：周邊液體栓塞劑市場分析 - 按應用

  • II型內漏
  • 畸形
  • 出血與創傷
  • 靜脈曲張
  • 腫瘤
  • 內臟動脈瘤

第 9 章：周邊液體栓塞劑市場 - 地理分析

  • 北美洲
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第 10 章：產業格局

  • 概述
  • 周邊液體栓塞劑市場的成長策略
  • 無機成長策略
    • 概述
  • 有機成長策略
    • 概述

第 11 章：公司簡介

  • Medtronic Plc
  • B Braun SE
  • Guerbet SA
  • Sirtex Medical Ltd
  • Balt
  • MicroVention Inc
  • Johnson & Johnson
  • GEM srl

第 12 章：附錄

Product Code: TIPRE00039169

The peripheral liquid embolic agents market is expected to grow from US$ 40.42 million in 2023 to US$ 81.41 million by 2031; it is anticipated to record a CAGR of 9.1% from 2023 to 2031.

Peripheral liquid embolic agents are substances used in interventional radiology procedures to block leaking blood vessel and malformations. These agents solidify after injecting which forms plug and block the blood flow to the targeted area.

Developments in Temperature-Induced Phase Change Systems and pH-Triggered Embolic Agents Acts as a Trend for Market Growth

Liquid embolism is a topic of great interest in bioengineering, particularly in peripheral procedures. Liquid embolic agents can penetrate peripheral, nidus, or distal areas where coils or catheters cannot reach. Although currently used liquid embolic agents can meet most clinical needs, they have some shortcomings. Therefore, various novel liquid embolic agents have been developed to improve imaging characteristics, reduce complications, optimize flow performance, and achieve drug loading capability. The systematic investigation of additional important material characteristics such as associated side effects (e.g., toxicity and adhesion), biofunctional (biocompatibility, biodegradability, biomechanics, and bioactivity), and radiopacity is essential for the development of clinically tailored embolic agents in the field of minimally invasive imaging procedures.

Temperature-sensitive polymer solutions can change from a sol-injectable state to a gel state at room temperature in the body. Poly(N-isopropyl acrylamide) (PNIPAAm) exhibits a reversible phase transition in response to a lower critical solution temperature (LCST) of 32 °C. According to a study published in the Journal of Controlled Release by Qian et al. in 2015, poly(N-isopropylacrylamide-co-butylmethyl acrylate) gels with iohexol dispersions for TACE of liver cancer demonstrated effective embolization of renal arteries in rabbits and sustained release of doxorubicin. Similarly, as per a study published in the National Library of Medicine by Wang et al. in 2011, chitosan/B-glycerophosphate (C/GP) successfully closed renal arteries in rabbits, indicating to be a potential embolization agent. Likewise, Zhao et al. also investigated temperature-sensitive PNIPAAm-iohexol nano gels for embolization, according to a research study published Wiley Online Library in 2011. The hydrophobic interactions above the phase transition temperature (36.5 °C) lead to a hierarchical 3D gel network for in situ vessel casting. Compared to Lipiodol, a peripheral embolic agent, the nanogel provided better peripheral embolization in VX2 liver tumors in rabbits.

Furthermore, a poloxamer 407 (a triblock copolymer of polyethylene oxide a-polypropylene oxide b-polyethylene oxide a) containing a thermosensitive liquid embolic hydrogel has been proposed for liver cancer therapy. This composite hydrogel composed of poloxamer 407, hydroxymethyl cellulose, sodium alginate, and iodixanol (PSHI) presented two phases with increasing temperature: a flowing sol and a shrunken gel. Notably, complete occlusion of the VX2 liver cancer model was demonstrated with PSHI-Ca2+ as the tumor disappeared after embolization.

pH-sensitive active ingredients undergo a phase transition due to the pH change between the in vitro and physiological environments. These hydrogels swell and collapse in response to pH, which is used to control drug release.

As per a study published in the Royal Society of Chemistry by Nguyen et al. in 2016, PCLA-PUSSM, a copolymer consisting of poly(ε-caprolactone-co-lactide) (PCLA), PEG, and poly(urethane sulfide sulfamethazine) (PUSSM) was developed, for TACE of HCC. This biodegradable material was loaded with doxorubicin and exhibited a phase transition in response to decreasing pH. The hydrogel successfully embolized a liver tumor from a VX2 rabbit tumor model while providing a sustained release of doxorubicin. In a rat model, embolization stopped blood supply to the tumor, creating an acidic environment through hypoxia and inducing lactic acidosis. The low pH triggered drug release and successfully inhibited tumor growth in vivo.

Some of the liquid embolic agents under trial for temperature-sensitive and pH-triggered are given below:

  • Table 1. Liquid Embolic Agents Under Trial for Temperature-Sensitive and pH-Triggered Gelation

Liquid Embolic Agents Mechanism Advantage Classical Usage Scenarios or Trial Conditions

Chitosan/B- glycerophosphate (chitosan/B-GP) Temperature- and pH-triggered gelation Drug delivery Renal arteries in rabbits

Silk-Elastin-Like proteins (SELPs) Temperature- triggered gelation Drug delivery Primary VX2 liver tumors in rabbit

Poly(N-isopropylacrylamide-co-butyl methylacrylate) nanogel (PIB nanogel) Temperature- triggered gelation A better embolization than lipiodol Primary VX2 liver tumors in rabbit

Poloxamer 407 Temperature- triggered gelation Temporary vascular occlusion Renal arteries in canines

poloxamer 407, sodium alginate, hydroxymethyl cellulose, iodixanol, and calcium ions (PSHI-Ca2+) Temperature- triggered gelation Radiopacity Primary VX2 liver tumors in rabbit

Sulfamethazine-based hydrogel pH-triggered gelation Drug delivery Primary VX2 liver tumors in rabbit

Poly(Amino Ester Urethane) block polymer (PEAU) Temperature- and pH-triggered gelation Drug delivery Primary VX2 liver tumors in rabbit

Thus, the growing focus and developments on temperature-induced phase change systems and pH-triggered embolic agents are expected to bring new trends in the peripheral liquid embolic agents market in the coming years.

The peripheral liquid embolic agents market analysis has been carried out by considering the following segments: type, application and geography. Based on type, the peripheral liquid embolic agents market is bifurcated into polymerizing liquid embolic agents and precipitating liquid embolic agents. In terms of application, the peripheral liquid embolic agents market is classified into endoleak type II, malformations, bleedings and trauma, varicose vein, tumors, and visceral aneurysm..

The scope of the peripheral liquid embolic agents market report covers North America (the US, Canada, and Mexico), Europe (Spain, the UK, Germany, France, Italy, and the Rest of Europe), Asia Pacific (South Korea, China, Japan, India, Australia, and the Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). North America is the biggest contributor to the global peripheral liquid embolic agents market. Asia Pacific is predicted to show the highest CAGR in the market during 2023-2031.

The North America regional market growth is attributed to the increasing cases of aneurysms, trauma, and others across the region. The market in Canada is anticipated to grow because of rising government support for addressing the increasing concerns regarding peripheral disorders. The market in Mexico is estimated to grow owing to the growing pharma industries and medical tourism. The Asia Pacific peripheral liquid embolic agents market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The market growth in the region is driven by various factors such as the rising prevalence of peripheral artery diseases (PAD), increasing demand for minimally invasive procedures, growing number of hospitals and ambulatory surgery centers, rising focus on developing countries by market players , and developing healthcare infrastructure in Asia Pacific

Centers for Disease Control and Prevention (CDC), European Medicines Agency (EMA), The Pan American Health Organization (PAHO), and World Health Organization (WHO) are a few key primary and secondary sources referred to while preparing the report on the peripheral liquid embolic agents market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Peripheral Liquid Embolic Agents Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Regional Pricing Analysis, 2023

5. Peripheral Liquid Embolic Agents Market - Key Market Dynamics

  • 5.1 Peripheral Liquid Embolic Agents Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Rising Incidence of Peripheral Vascular Diseases
    • 5.2.2 Increasing Demand for Minimally Invasive Procedures
  • 5.3 Market Restraints
    • 5.3.1 High Cost of Embolization Agents
  • 5.4 Market Opportunities
    • 5.4.1 Growing Strategic Initiatives by Market Players
  • 5.5 Future Trends
    • 5.5.1 Developments in Temperature-Induced Phase Change Systems and pH-Triggered Embolic Agents
  • 5.6 Impact analysis

6. Peripheral Liquid Embolic Agents Market - Global Market Analysis

  • 6.1 Peripheral Liquid Embolic Agents Market Revenue (US$ Thousand), 2021-2031
  • 6.2 Peripheral Liquid Embolic Agents Market Analysis
  • 6.3 Market Positioning Analysis, 2023

7. Peripheral Liquid Embolic Agents Market Analysis - by Type

  • 7.1 Polymerizing Liquid Embolic Agent
    • 7.1.1 Overview
    • 7.1.2 Polymerizing Liquid Embolic Agent: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 7.2 Precipitating Liquid Embolic Agent
    • 7.2.1 Overview
    • 7.2.2 Precipitating Liquid Embolic Agent: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)

8. Peripheral Liquid Embolic Agents Market Analysis - by Application

  • 8.1 Endoleak Type II
    • 8.1.1 Overview
    • 8.1.2 Endoleak Type II: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 8.2 Malformations
    • 8.2.1 Overview
    • 8.2.2 Malformations: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 8.3 Bleedings and Trauma
    • 8.3.1 Overview
    • 8.3.2 Bleedings and Trauma: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 8.4 Varicose Vein
    • 8.4.1 Overview
    • 8.4.2 Varicose Vein: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 8.5 Tumours
    • 8.5.1 Overview
    • 8.5.2 Tumours: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 8.6 Visceral Aneurysm
    • 8.6.1 Overview
    • 8.6.2 Visceral Aneurysm: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)

9. Peripheral Liquid Embolic Agents Market - Geographical Analysis

  • 9.1 North America
    • 9.1.1 North America Peripheral Liquid Embolic Agents Market Overview
    • 9.1.2 North America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
      • 9.1.2.1 North America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Type
      • 9.1.2.2 North America: Peripheral Liquid Embolic Agents Market - Volume and Forecast Analysis - by Type
        • 9.1.2.2.1 North America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Polymerizing Liquid Embolic Agent
        • 9.1.2.2.2 North America: Peripheral Liquid Embolic Agents Market - Volume and Forecast Analysis - by Polymerizing Liquid Embolic Agent
        • 9.1.2.2.3 North America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Precipitating Liquid Embolic Agent
        • 9.1.2.2.4 North America: Peripheral Liquid Embolic Agents Market - Volume and Forecast Analysis - by Precipitating Liquid Embolic Agent
      • 9.1.2.3 North America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Application
    • 9.1.3 North America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Country
      • 9.1.3.1 Canada: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.1.3.1.1 Canada: Peripheral Liquid Embolic Agents Market Breakdown, by Type
        • 9.1.3.1.1.1 Canada: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
        • 9.1.3.1.1.2 Canada: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
        • 9.1.3.1.2 Canada: Peripheral Liquid Embolic Agents Market Breakdown, by Application
      • 9.1.3.2 Mexico: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.1.3.2.1 Mexico: Peripheral Liquid Embolic Agents Market Breakdown, by Type
        • 9.1.3.2.1.1 Mexico: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
        • 9.1.3.2.1.2 Mexico: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
        • 9.1.3.2.2 Mexico: Peripheral Liquid Embolic Agents Market Breakdown, by Application
  • 9.2 Europe
    • 9.2.1 Europe Peripheral Liquid Embolic Agents Market Overview
    • 9.2.2 Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
      • 9.2.2.1 Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Type
      • 9.2.2.2 Europe: Peripheral Liquid Embolic Agents Market - Volume and Forecast Analysis - by Type
        • 9.2.2.2.1 Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Polymerizing Liquid Embolic Agent
        • 9.2.2.2.2 Europe: Peripheral Liquid Embolic Agents Market - Volume and Forecast Analysis - by Polymerizing Liquid Embolic Agent
        • 9.2.2.2.3 Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Precipitating Liquid Embolic Agent
        • 9.2.2.2.4 Europe: Peripheral Liquid Embolic Agents Market - Volume and Forecast Analysis - by Precipitating Liquid Embolic Agent
      • 9.2.2.3 Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Application
    • 9.2.3 Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Country
      • 9.2.3.1 Germany: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.2.3.1.1 Germany: Peripheral Liquid Embolic Agents Market Breakdown, by Type
        • 9.2.3.1.1.1 Germany: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
        • 9.2.3.1.1.2 Germany: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
        • 9.2.3.1.2 Germany: Peripheral Liquid Embolic Agents Market Breakdown, by Application
      • 9.2.3.2 United Kingdom: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.2.3.2.1 United Kingdom: Peripheral Liquid Embolic Agents Market Breakdown, by Type
        • 9.2.3.2.1.1 United Kingdom: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
        • 9.2.3.2.1.2 United Kingdom: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
        • 9.2.3.2.2 United Kingdom: Peripheral Liquid Embolic Agents Market Breakdown, by Application
      • 9.2.3.3 France: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.2.3.3.1 France: Peripheral Liquid Embolic Agents Market Breakdown, by Type
        • 9.2.3.3.1.1 France: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
        • 9.2.3.3.1.2 France: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
        • 9.2.3.3.2 France: Peripheral Liquid Embolic Agents Market Breakdown, by Application
      • 9.2.3.4 Italy: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.2.3.4.1 Italy: Peripheral Liquid Embolic Agents Market Breakdown, by Type
        • 9.2.3.4.1.1 Italy: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
        • 9.2.3.4.1.2 Italy: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
        • 9.2.3.4.2 Italy: Peripheral Liquid Embolic Agents Market Breakdown, by Application
      • 9.2.3.5 Spain: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.2.3.5.1 Spain: Peripheral Liquid Embolic Agents Market Breakdown, by Type
        • 9.2.3.5.1.1 Spain: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
        • 9.2.3.5.1.2 Spain: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
        • 9.2.3.5.2 Spain: Peripheral Liquid Embolic Agents Market Breakdown, by Application
      • 9.2.3.6 Rest of Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.2.3.6.1 Rest of Europe: Peripheral Liquid Embolic Agents Market Breakdown, by Type
        • 9.2.3.6.1.1 Rest of Europe: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
        • 9.2.3.6.1.2 Rest of Europe: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
        • 9.2.3.6.2 Rest of Europe: Peripheral Liquid Embolic Agents Market Breakdown, by Application
  • 9.3 Asia Pacific
    • 9.3.1 Asia Pacific Peripheral Liquid Embolic Agents Market Overview
    • 9.3.2 Asia Pacific: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
      • 9.3.2.1 Asia Pacific: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Type
      • 9.3.2.2 Asia Pacific: Peripheral Liquid Embolic Agents Market - Volume and Forecast Analysis - by Type
        • 9.3.2.2.1 Asia Pacific: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Polymerizing Liquid Embolic Agent
        • 9.3.2.2.2 Asia Pacific: Peripheral Liquid Embolic Agents Market - Volume and Forecast Analysis - by Polymerizing Liquid Embolic Agent
        • 9.3.2.2.3 Asia Pacific: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Precipitating Liquid Embolic Agent
        • 9.3.2.2.4 Asia Pacific: Peripheral Liquid Embolic Agents Market - Volume and Forecast Analysis - by Precipitating Liquid Embolic Agent
      • 9.3.2.3 Asia Pacific: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Application
    • 9.3.3 Asia Pacific: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Country
      • 9.3.3.1 China: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.3.3.1.1 China: Peripheral Liquid Embolic Agents Market Breakdown, by Type
        • 9.3.3.1.1.1 China: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
        • 9.3.3.1.1.2 China: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
        • 9.3.3.1.2 China: Peripheral Liquid Embolic Agents Market Breakdown, by Application
      • 9.3.3.2 Japan: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.3.3.2.1 Japan: Peripheral Liquid Embolic Agents Market Breakdown, by Type
        • 9.3.3.2.1.1 Japan: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
        • 9.3.3.2.1.2 Japan: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
        • 9.3.3.2.2 Japan: Peripheral Liquid Embolic Agents Market Breakdown, by Application
      • 9.3.3.3 India: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.3.3.3.1 India: Peripheral Liquid Embolic Agents Market Breakdown, by Type
        • 9.3.3.3.1.1 India: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
        • 9.3.3.3.1.2 India: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
        • 9.3.3.3.2 India: Peripheral Liquid Embolic Agents Market Breakdown, by Application
      • 9.3.3.4 Australia: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.3.3.4.1 Australia: Peripheral Liquid Embolic Agents Market Breakdown, by Type
        • 9.3.3.4.1.1 Australia: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
        • 9.3.3.4.1.2 Australia: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
        • 9.3.3.4.2 Australia: Peripheral Liquid Embolic Agents Market Breakdown, by Application
      • 9.3.3.5 South Korea: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.3.3.5.1 South Korea: Peripheral Liquid Embolic Agents Market Breakdown, by Type
        • 9.3.3.5.1.1 South Korea: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
        • 9.3.3.5.1.2 South Korea: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
        • 9.3.3.5.2 South Korea: Peripheral Liquid Embolic Agents Market Breakdown, by Application
      • 9.3.3.6 Rest of APAC: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.3.3.6.1 Rest of APAC: Peripheral Liquid Embolic Agents Market Breakdown, by Type
        • 9.3.3.6.1.1 Rest of APAC: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
        • 9.3.3.6.1.2 Rest of APAC: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
        • 9.3.3.6.2 Rest of APAC: Peripheral Liquid Embolic Agents Market Breakdown, by Application
  • 9.4 Middle East & Africa
    • 9.4.1 Middle East & Africa Peripheral Liquid Embolic Agents Market Overview
    • 9.4.2 Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
      • 9.4.2.1 Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Type
      • 9.4.2.2 Middle East & Africa: Peripheral Liquid Embolic Agents Market - Volume and Forecast Analysis - by Type
        • 9.4.2.2.1 Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Polymerizing Liquid Embolic Agent
        • 9.4.2.2.2 Middle East & Africa: Peripheral Liquid Embolic Agents Market - Volume and Forecast Analysis - by Polymerizing Liquid Embolic Agent
        • 9.4.2.2.3 Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Precipitating Liquid Embolic Agent
        • 9.4.2.2.4 Middle East & Africa: Peripheral Liquid Embolic Agents Market - Volume and Forecast Analysis - by Precipitating Liquid Embolic Agent
      • 9.4.2.3 Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Application
    • 9.4.3 Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Country
      • 9.4.3.1 Saudi Arabia: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.4.3.1.1 Saudi Arabia: Peripheral Liquid Embolic Agents Market Breakdown, by Type
        • 9.4.3.1.1.1 Saudi Arabia: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
        • 9.4.3.1.1.2 Saudi Arabia: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
        • 9.4.3.1.2 Saudi Arabia: Peripheral Liquid Embolic Agents Market Breakdown, by Application
      • 9.4.3.2 South Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.4.3.2.1 South Africa: Peripheral Liquid Embolic Agents Market Breakdown, by Type
        • 9.4.3.2.1.1 South Africa: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
        • 9.4.3.2.1.2 South Africa: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
        • 9.4.3.2.2 South Africa: Peripheral Liquid Embolic Agents Market Breakdown, by Application
      • 9.4.3.3 United Arab Emirates: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.4.3.3.1 United Arab Emirates: Peripheral Liquid Embolic Agents Market Breakdown, by Type
        • 9.4.3.3.1.1 United Arab Emirates: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
        • 9.4.3.3.1.2 United Arab Emirates: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
        • 9.4.3.3.2 United Arab Emirates: Peripheral Liquid Embolic Agents Market Breakdown, by Application
      • 9.4.3.4 Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.4.3.4.1 Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market Breakdown, by Type
        • 9.4.3.4.1.1 Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
        • 9.4.3.4.1.2 Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
        • 9.4.3.4.2 Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market Breakdown, by Application
  • 9.5 South and Central America
    • 9.5.1 South and Central America Peripheral Liquid Embolic Agents Market Overview
    • 9.5.2 South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
      • 9.5.2.1 South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Type
      • 9.5.2.2 South and Central America: Peripheral Liquid Embolic Agents Market - Volume and Forecast Analysis - by Type
        • 9.5.2.2.1 South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Polymerizing Liquid Embolic Agent
        • 9.5.2.2.2 South and Central America: Peripheral Liquid Embolic Agents Market - Volume and Forecast Analysis - by Polymerizing Liquid Embolic Agent
        • 9.5.2.2.3 South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Precipitating Liquid Embolic Agent
        • 9.5.2.2.4 South and Central America: Peripheral Liquid Embolic Agents Market - Volume and Forecast Analysis - by Precipitating Liquid Embolic Agent
      • 9.5.2.3 South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Application
    • 9.5.3 South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Country
      • 9.5.3.1 Brazil: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.5.3.1.1 Brazil: Peripheral Liquid Embolic Agents Market Breakdown, by Type
        • 9.5.3.1.1.1 Brazil: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
        • 9.5.3.1.1.2 Brazil: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
        • 9.5.3.1.2 Brazil: Peripheral Liquid Embolic Agents Market Breakdown, by Application
      • 9.5.3.2 Argentina: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.5.3.2.1 Argentina: Peripheral Liquid Embolic Agents Market Breakdown, by Type
        • 9.5.3.2.1.1 Argentina: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
        • 9.5.3.2.1.2 Argentina: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
        • 9.5.3.2.2 Argentina: Peripheral Liquid Embolic Agents Market Breakdown, by Application
      • 9.5.3.3 Rest of South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.5.3.3.1 Rest of South and Central America: Peripheral Liquid Embolic Agents Market Breakdown, by Type
        • 9.5.3.3.1.1 Rest of South and Central America: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
        • 9.5.3.3.1.2 Rest of South and Central America: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
        • 9.5.3.3.2 Rest of South and Central America: Peripheral Liquid Embolic Agents Market Breakdown, by Application

10. Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in the Peripheral Liquid Embolic Agents Market
  • 10.3 Inorganic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Organic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 Medtronic Plc
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 B Braun SE
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Guerbet SA
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Sirtex Medical Ltd
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Balt
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 MicroVention Inc
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Johnson & Johnson
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 GEM srl
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments

12. Appendix

  • 12.1 About The Insight Partners
  • 12.2 Glossary of Terms

List Of Tables

  • Table 1. Peripheral Liquid Embolic Agents Market Segmentation
  • Table 2. Regional Pricing Analysis, Price (US$)/ML, 2023
  • Table 3. Liquid Embolic Agents Under Trial for Temperature-Sensitive and pH-Triggered Gelation
  • Table 4. Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 5. Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 6. North America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 7. North America: Peripheral Liquid Embolic Agents Market - Volume and Forecast to 2031(ML) - by Type
  • Table 8. North America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 9. North America: Peripheral Liquid Embolic Agents Market - Volume and Forecast to 2031(ML) - by Polymerizing Liquid Embolic Agent
  • Table 10. North America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 11. North America: Peripheral Liquid Embolic Agents Market - Volume and Forecast to 2031(ML) - by Precipitating Liquid Embolic Agent
  • Table 12. North America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 13. Canada: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 14. Canada: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 15. Canada: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 16. Canada: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 17. Mexico: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 18. Mexico: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 19. Mexico: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 20. Mexico: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 21. Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 22. Europe: Peripheral Liquid Embolic Agents Market - Volume and Forecast to 2031(ML) - by Type
  • Table 23. Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 24. Europe: Peripheral Liquid Embolic Agents Market - Volume and Forecast to 2031(ML) - by Polymerizing Liquid Embolic Agent
  • Table 25. Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 26. Europe: Peripheral Liquid Embolic Agents Market - Volume and Forecast to 2031(ML) - by Precipitating Liquid Embolic Agent
  • Table 27. Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 28. Germany: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 29. Germany: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 30. Germany: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 31. Germany: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 32. United Kingdom: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 33. United Kingdom: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 34. United Kingdom: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 35. United Kingdom: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 36. France: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 37. France: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 38. France: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 39. France: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 40. Italy: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 41. Italy: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 42. Italy: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 43. Italy: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 44. Spain: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 45. Spain: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 46. Spain: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 47. Spain: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 48. Rest of Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 49. Rest of Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 50. Rest of Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 51. Rest of Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 52. Asia Pacific: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 53. Asia Pacific: Peripheral Liquid Embolic Agents Market - Volume and Forecast to 2031(ML) - by Type
  • Table 54. Asia Pacific: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 55. Asia Pacific: Peripheral Liquid Embolic Agents Market - Volume and Forecast to 2031(ML) - by Polymerizing Liquid Embolic Agent
  • Table 56. Asia Pacific: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 57. Asia Pacific: Peripheral Liquid Embolic Agents Market - Volume and Forecast to 2031(ML) - by Precipitating Liquid Embolic Agent
  • Table 58. Asia Pacific: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 59. China: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 60. China: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 61. China: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 62. China: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 63. Japan: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 64. Japan: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 65. Japan: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 66. Japan: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 67. India: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 68. India: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 69. India: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 70. India: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 71. Australia: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 72. Australia: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 73. Australia: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 74. Australia: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 75. South Korea: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 76. South Korea: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 77. South Korea: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 78. South Korea: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 79. Rest of APAC: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 80. Rest of APAC: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 81. Rest of APAC: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 82. Rest of APAC: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 83. Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 84. Middle East & Africa: Peripheral Liquid Embolic Agents Market - Volume and Forecast to 2031(ML) - by Type
  • Table 85. Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 86. Middle East & Africa: Peripheral Liquid Embolic Agents Market - Volume and Forecast to 2031(ML) - by Polymerizing Liquid Embolic Agent
  • Table 87. Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 88. Middle East & Africa: Peripheral Liquid Embolic Agents Market - Volume and Forecast to 2031(ML) - by Precipitating Liquid Embolic Agent
  • Table 89. Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 90. Saudi Arabia: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 91. Saudi Arabia: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 92. Saudi Arabia: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 93. Saudi Arabia: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 94. South Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 95. South Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 96. South Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 97. South Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 98. United Arab Emirates: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 99. United Arab Emirates: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 100. United Arab Emirates: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 101. United Arab Emirates: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 102. Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 103. Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 104. Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 105. Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 106. South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 107. South and Central America: Peripheral Liquid Embolic Agents Market - Volume and Forecast to 2031(ML) - by Type
  • Table 108. South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 109. South and Central America: Peripheral Liquid Embolic Agents Market - Volume and Forecast to 2031(ML) - by Polymerizing Liquid Embolic Agent
  • Table 110. South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 111. South and Central America: Peripheral Liquid Embolic Agents Market - Volume and Forecast to 2031(ML) - by Precipitating Liquid Embolic Agent
  • Table 112. South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 113. Brazil: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 114. Brazil: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 115. Brazil: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 116. Brazil: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 117. Argentina: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 118. Argentina: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 119. Argentina: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 120. Argentina: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 121. Rest of South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 122. Rest of South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
  • Table 123. Rest of South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
  • Table 124. Rest of South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
  • Table 125. Recent Inorganic Growth Strategies in the Peripheral Liquid Embolic Agents Market
  • Table 126. Recent Organic Growth Strategies in the Peripheral Liquid Embolic Agents Market
  • Table 127. Glossary of Terms, Peripheral Liquid Embolic Agents Market

List Of Figures

  • Figure 1. Peripheral Liquid Embolic Agents Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Peripheral Liquid Embolic Agents Market Revenue (US$ Thousand), 2021-2031
  • Figure 5. Manufacturers Market Positioning, 2023
  • Figure 6. Peripheral Liquid Embolic Agents Market Share (%) - by Type (2023 and 2031)
  • Figure 7. Polymerizing Liquid Embolic Agent: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 8. Precipitating Liquid Embolic Agent: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 9. Peripheral Liquid Embolic Agents Market Share (%) - by Application (2023 and 2031)
  • Figure 10. Endoleak Type II: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 11. Malformations: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 12. Bleedings and Trauma: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 13. Varicose Vein: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 14. Tumours: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 15. Visceral Aneurysm: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 16. North America Peripheral Liquid Embolic Agents Market by Key Countries, 2023
  • Figure 17. North America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 18. North America: Peripheral Liquid Embolic Agents Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 19. Canada: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 20. Mexico: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 21. Europe Peripheral Liquid Embolic Agents Market by Key Countries, 2023
  • Figure 22. Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 23. Europe: Peripheral Liquid Embolic Agents Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 24. Germany: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 25. United Kingdom: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 26. France: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 27. Italy: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 28. Spain: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 29. Rest of Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 30. Asia Pacific Peripheral Liquid Embolic Agents Market by Key Countries, 2023
  • Figure 31. Asia Pacific: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 32. Asia Pacific: Peripheral Liquid Embolic Agents Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 33. China: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 34. Japan: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 35. India: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 36. Australia: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 37. South Korea: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 38. Rest of APAC: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 39. Middle East & Africa Peripheral Liquid Embolic Agents Market by Key Countries, 2023
  • Figure 40. Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 41. Middle East & Africa: Peripheral Liquid Embolic Agents Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 42. Saudi Arabia: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 43. South Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 44. United Arab Emirates: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 45. Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 46. South & Central America Peripheral Liquid Embolic Agents Market by Key Countries, 2023
  • Figure 47. South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 48. South and Central America: Peripheral Liquid Embolic Agents Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 49. Brazil: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 50. Argentina: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 51. Rest of South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 52. Growth Strategies in the Peripheral Liquid Embolic Agents Market